124 related articles for article (PubMed ID: 36355233)
1. Attributable disease burden related to low bone mineral density in Iran from 1990 to 2019: results from the Global Burden of Disease 2019.
Azangou-Khyavy M; Saeedi Moghaddam S; Mohammadi E; Shobeiri P; Rashidi MM; Ahmadi N; Shahsavan S; Shirzad Moghaddam Z; Sohrabi H; Pourghasem F; Kalantar R; Ghaffari A; Hashemi SM; Rezaei N; Larijani B
Arch Osteoporos; 2022 Nov; 17(1):140. PubMed ID: 36355233
[TBL] [Abstract][Full Text] [Related]
2. Low bone mineral density, a neglected condition in North Africa and Middle East: estimates from the Global Burden of Disease Study, 1990-2019.
Rashidi MM; Saeedi Moghaddam S; Azadnajafabad S; Heidari-Foroozan M; Hashemi SM; Mohammadi E; Esfahani Z; Ebrahimi N; Shobeiri P; Malekpour MR; Abbasi-Kangevari M; Rashedi S; Mohammadi Fateh S; Larijani B; Farzadfar F
Osteoporos Int; 2023 Sep; 34(9):1577-1589. PubMed ID: 37217657
[TBL] [Abstract][Full Text] [Related]
3. The global burden attributable to low bone mineral density.
Sànchez-Riera L; Carnahan E; Vos T; Veerman L; Norman R; Lim SS; Hoy D; Smith E; Wilson N; Nolla JM; Chen JS; Macara M; Kamalaraj N; Li Y; Kok C; Santos-Hernández C; March L
Ann Rheum Dis; 2014 Sep; 73(9):1635-45. PubMed ID: 24692584
[TBL] [Abstract][Full Text] [Related]
4. The pattern and trends of disease burden due to low bone mineral density from 1990 to 2019 in China: findings from the Global Burden of Disease Study 2019.
Chen Z; Wen Y; Qiu M; Fang L; Jin O; Gu J
Arch Osteoporos; 2022 Mar; 17(1):39. PubMed ID: 35247103
[TBL] [Abstract][Full Text] [Related]
5. Trend in global burden attributable to low bone mineral density in different WHO regions: 2000 and beyond, results from the Global Burden of Disease (GBD) study 2019.
Panahi N; Saeedi Moghaddam S; Fahimfar N; Rezaei N; Sanjari M; Rashidi MM; Shobeiri P; Larijani B; Ostovar A
Endocr Connect; 2023 Oct; 12(10):. PubMed ID: 37578756
[TBL] [Abstract][Full Text] [Related]
6. Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019.
Moradi S; Parsaei A; Saeedi Moghaddam S; Aryannejad A; Azadnajafabad S; Rezaei N; Mashinchi B; Esfahani Z; Shobeiri P; Rezaei N; ; Naghavi M; Larijani B; Farzadfar F
Front Public Health; 2023; 11():1149719. PubMed ID: 37325329
[TBL] [Abstract][Full Text] [Related]
7. Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990-2019.
Nejadghaderi SA; Saeedi Moghaddam S; Keykhaei M; Shobeiri P; Rezaei N; Rezaei N; Naghavi M; Larijani B; Farzadfar F
Front Endocrinol (Lausanne); 2023; 14():1115833. PubMed ID: 36923218
[TBL] [Abstract][Full Text] [Related]
8. National, subnational and risk attributed burden of chronic respiratory diseases in Iran from 1990 to 2019.
Heidari-Foroozan M; Aryan A; Esfahani Z; Shahrbaf MA; Moghaddam SS; Keykhaei M; Ghasemi E; Rashidi MM; Rezaei N; Ghamari SH; Abbasi-Kangevari M; Fateh SM; Farzi Y; Rezaei N; Larijani B
Respir Res; 2023 Mar; 24(1):74. PubMed ID: 36906596
[TBL] [Abstract][Full Text] [Related]
9. Global, Regional, and National Burden of Low Bone Mineral Density From 1990 to 2019: Results From the Global Burden of Disease Study 2019.
Dong Y; Kang H; Peng R; Song K; Guo Q; Guan H; Zhu M; Ye D; Li F
Front Endocrinol (Lausanne); 2022; 13():870905. PubMed ID: 35685212
[TBL] [Abstract][Full Text] [Related]
10. National and subnational burden of brain and central nervous system cancers in Iran, 1990-2019: Results from the global burden of disease study 2019.
Mahdavi M; Moghaddam SS; Abbasi-Kangevari M; Mohammadi E; Shobeiri P; Sharifi G; Jafari A; Rezaei N; Ebrahimi N; Rezaei N; Ghamari SH; Malekpour MR; Khalili M; Larijani B; Kompani F
Cancer Med; 2023 Apr; 12(7):8614-8628. PubMed ID: 36622061
[TBL] [Abstract][Full Text] [Related]
11. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
12. Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Iran Collaborators
Lancet; 2022 Apr; 399(10335):1625-1645. PubMed ID: 35397236
[TBL] [Abstract][Full Text] [Related]
13. Trends in prevalence, mortality, and morbidity associated with high systolic blood pressure in Brazil from 1990 to 2017: estimates from the "Global Burden of Disease 2017" (GBD 2017) study.
Nascimento BR; Brant LCC; Yadgir S; Oliveira GMM; Roth G; Glenn SD; Mooney M; Naghavi M; Passos VMA; Duncan BB; Silva DAS; Malta DC; Ribeiro ALP
Popul Health Metr; 2020 Sep; 18(Suppl 1):17. PubMed ID: 32993676
[TBL] [Abstract][Full Text] [Related]
14. National and subnational mortality and disability-adjusted life years (DALYs) attributable to 17 occupational risk factors in Iran, 1990-2015.
Abtahi M; Koolivand A; Dobaradaran S; Yaghmaeian K; Khaloo SS; Jorfi S; Keshmiri S; Nafez AH; Saeedi R
Environ Res; 2018 Aug; 165():158-175. PubMed ID: 29705621
[TBL] [Abstract][Full Text] [Related]
15. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.
Dai H; Alsalhe TA; Chalghaf N; Riccò M; Bragazzi NL; Wu J
PLoS Med; 2020 Jul; 17(7):e1003198. PubMed ID: 32722671
[TBL] [Abstract][Full Text] [Related]
16. The Global Burden of Osteoporosis, Low Bone Mass, and Its Related Fracture in 204 Countries and Territories, 1990-2019.
Shen Y; Huang X; Wu J; Lin X; Zhou X; Zhu Z; Pan X; Xu J; Qiao J; Zhang T; Ye L; Jiang H; Ren Y; Shan PF
Front Endocrinol (Lausanne); 2022; 13():882241. PubMed ID: 35669691
[TBL] [Abstract][Full Text] [Related]
17. Burden of musculoskeletal disorders in Iran during 1990-2017: estimates from the Global Burden of Disease Study 2017.
Shahrezaee M; Keshtkari S; Moradi-Lakeh M; Abbasifard M; Alipour V; Amini S; Arabloo J; Arzani A; Bakhshaei M; Barzegar A; Bijani A; Dianatinasab M; Eskandarieh S; Gheshlagh RG; Ghashghaee A; Heidari-Soureshjani R; Irvani SSN; Lahimchi A; Maleki S; Manafi N; Manafi A; Mansournia MA; Mohammadian-Hafshejani A; Bandpei MAM; Moradzadeh R; Naderi M; Pakshir K; Rafiei A; Rashedi V; Rezaei N; Rezapour A; Sahraian MA; Shahabi S; Shamsi M; Soheili A; Soroush A; Zamani M; Mohajer B; Farzadfar F
Arch Osteoporos; 2020 Jul; 15(1):103. PubMed ID: 32651719
[TBL] [Abstract][Full Text] [Related]
18. National and sub-national age-sex specific and cause-specific mortality and disability-adjusted life years (DALYs) attributable to household air pollution from solid cookfuel use (HAP) in Iran, 1990-2013.
Abtahi M; Koolivand A; Dobaradaran S; Yaghmaeian K; Mohseni-Bandpei A; Khaloo SS; Jorfi S; Saeedi R
Environ Res; 2017 Jul; 156():87-96. PubMed ID: 28340488
[TBL] [Abstract][Full Text] [Related]
19. Trends in health burden of ambient particulate matter pollution in Iran, 1990-2010: findings from the Global Burden of Disease study 2010.
Poursafa P; Kelishadi R; Ghasemian A; Sharifi F; Djalalinia S; Khajavi A; Nejatifar M; Asayesh H; Mansourian M; Qorbani M; Ansari H
Environ Sci Pollut Res Int; 2015 Dec; 22(23):18645-53. PubMed ID: 26490896
[TBL] [Abstract][Full Text] [Related]
20. National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019.
Azangou-Khyavy M; Saeedi Moghaddam S; Rezaei N; Esfahani Z; Rezaei N; Azadnajafabad S; Rashidi MM; Mohammadi E; ; Tavangar SM; Jamshidi H; Mokdad AH; Naghavi M; Farzadfar F; Larijani B
Sci Rep; 2022 Aug; 12(1):13231. PubMed ID: 35918489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
